Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Macular Degeneration | 17 | 2024 | 1015 | 4.220 |
Why?
|
Dark Adaptation | 6 | 2023 | 224 | 2.730 |
Why?
|
Fluorescein Angiography | 32 | 2024 | 1086 | 2.230 |
Why?
|
Tomography, Optical Coherence | 33 | 2024 | 2957 | 2.000 |
Why?
|
Retinal Diseases | 8 | 2022 | 710 | 1.990 |
Why?
|
Wet Macular Degeneration | 6 | 2024 | 165 | 1.980 |
Why?
|
Metabolomics | 9 | 2024 | 1674 | 1.720 |
Why?
|
Visual Acuity | 26 | 2024 | 2714 | 1.700 |
Why?
|
Retinal Vessels | 17 | 2024 | 864 | 1.440 |
Why?
|
Diabetic Retinopathy | 16 | 2024 | 1300 | 1.430 |
Why?
|
Vitreous Body | 6 | 2018 | 401 | 1.220 |
Why?
|
Choroid | 11 | 2024 | 364 | 1.190 |
Why?
|
Fibrinolysin | 2 | 2016 | 130 | 1.000 |
Why?
|
Contrast Sensitivity | 7 | 2024 | 253 | 0.940 |
Why?
|
Fundus Oculi | 16 | 2024 | 560 | 0.910 |
Why?
|
Ophthalmology | 2 | 2021 | 560 | 0.900 |
Why?
|
Choroidal Neovascularization | 6 | 2017 | 364 | 0.840 |
Why?
|
Retina | 16 | 2022 | 2662 | 0.810 |
Why?
|
Geographic Atrophy | 4 | 2024 | 92 | 0.780 |
Why?
|
Porphyrins | 7 | 2006 | 352 | 0.690 |
Why?
|
Retinal Necrosis Syndrome, Acute | 1 | 2020 | 24 | 0.680 |
Why?
|
Retinal Vein Occlusion | 4 | 2024 | 149 | 0.680 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2021 | 204 | 0.680 |
Why?
|
Macula Lutea | 5 | 2024 | 180 | 0.650 |
Why?
|
Ophthalmologic Surgical Procedures | 2 | 2017 | 354 | 0.640 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2020 | 190 | 0.630 |
Why?
|
Light Coagulation | 1 | 2017 | 72 | 0.590 |
Why?
|
Photosensitizing Agents | 7 | 2006 | 629 | 0.590 |
Why?
|
Fatty Acids, Unsaturated | 2 | 2020 | 542 | 0.570 |
Why?
|
Metabolome | 3 | 2024 | 1009 | 0.550 |
Why?
|
Eye Diseases | 2 | 2020 | 660 | 0.540 |
Why?
|
Photochemotherapy | 7 | 2006 | 830 | 0.540 |
Why?
|
Vitreous Detachment | 1 | 2016 | 23 | 0.540 |
Why?
|
Vascular Endothelial Growth Factor A | 10 | 2024 | 3517 | 0.530 |
Why?
|
Retinal Drusen | 4 | 2024 | 78 | 0.520 |
Why?
|
Fibrinolytic Agents | 2 | 2016 | 2080 | 0.510 |
Why?
|
Eye Infections, Fungal | 1 | 2016 | 99 | 0.490 |
Why?
|
Retinal Detachment | 5 | 2024 | 429 | 0.470 |
Why?
|
Endophthalmitis | 2 | 2016 | 263 | 0.460 |
Why?
|
Fungi | 1 | 2016 | 345 | 0.440 |
Why?
|
Phospholipase C gamma | 2 | 2011 | 131 | 0.430 |
Why?
|
Eye Infections, Bacterial | 1 | 2016 | 239 | 0.430 |
Why?
|
Proto-Oncogene Proteins c-cbl | 2 | 2011 | 120 | 0.430 |
Why?
|
Cross-Sectional Studies | 22 | 2024 | 26379 | 0.420 |
Why?
|
Retinal Perforations | 2 | 2014 | 138 | 0.420 |
Why?
|
Telemedicine | 2 | 2021 | 3109 | 0.420 |
Why?
|
Lipids | 4 | 2022 | 3345 | 0.420 |
Why?
|
Angiogenesis Inhibitors | 5 | 2024 | 2057 | 0.420 |
Why?
|
Peptide Fragments | 2 | 2016 | 5151 | 0.410 |
Why?
|
Portugal | 2 | 2024 | 91 | 0.400 |
Why?
|
Ophthalmoscopes | 1 | 2012 | 21 | 0.400 |
Why?
|
Macular Edema | 5 | 2024 | 387 | 0.380 |
Why?
|
Retinal Artery | 1 | 2012 | 109 | 0.370 |
Why?
|
Vitrectomy | 5 | 2024 | 392 | 0.360 |
Why?
|
Intravitreal Injections | 5 | 2024 | 401 | 0.350 |
Why?
|
Nematode Infections | 1 | 2009 | 19 | 0.330 |
Why?
|
Retinitis | 1 | 2009 | 36 | 0.330 |
Why?
|
Eye Infections, Parasitic | 1 | 2009 | 27 | 0.320 |
Why?
|
Retinal Neovascularization | 4 | 2024 | 288 | 0.320 |
Why?
|
Aged | 39 | 2024 | 171502 | 0.310 |
Why?
|
Angiography | 2 | 2023 | 1597 | 0.300 |
Why?
|
Middle Aged | 38 | 2024 | 223487 | 0.270 |
Why?
|
Choroid Diseases | 3 | 2018 | 63 | 0.270 |
Why?
|
Microscopy, Confocal | 1 | 2012 | 1972 | 0.250 |
Why?
|
Prospective Studies | 19 | 2024 | 54924 | 0.250 |
Why?
|
Artificial Intelligence | 1 | 2020 | 2666 | 0.250 |
Why?
|
Humans | 71 | 2024 | 768171 | 0.250 |
Why?
|
Bacteria | 1 | 2016 | 2216 | 0.250 |
Why?
|
Photoreceptor Cells, Vertebrate | 2 | 2018 | 203 | 0.240 |
Why?
|
Diagnostic Techniques, Ophthalmological | 2 | 2018 | 252 | 0.240 |
Why?
|
Neovascularization, Pathologic | 5 | 2023 | 2631 | 0.230 |
Why?
|
Glaucoma, Neovascular | 1 | 2023 | 37 | 0.220 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5367 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.200 |
Why?
|
Aged, 80 and over | 15 | 2024 | 59626 | 0.200 |
Why?
|
Epiretinal Membrane | 1 | 2022 | 73 | 0.200 |
Why?
|
Blindness | 2 | 2023 | 587 | 0.200 |
Why?
|
Female | 42 | 2024 | 397187 | 0.190 |
Why?
|
Male | 42 | 2024 | 364731 | 0.190 |
Why?
|
Scleral Buckling | 3 | 2024 | 95 | 0.190 |
Why?
|
Macaca fascicularis | 8 | 2006 | 912 | 0.180 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 3 | 2024 | 662 | 0.180 |
Why?
|
Vitreous Hemorrhage | 1 | 2021 | 47 | 0.180 |
Why?
|
Disease Models, Animal | 10 | 2019 | 18349 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8747 | 0.170 |
Why?
|
Follow-Up Studies | 11 | 2024 | 39354 | 0.170 |
Why?
|
Fovea Centralis | 1 | 2020 | 126 | 0.170 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5891 | 0.170 |
Why?
|
Prosthesis Implantation | 1 | 2004 | 594 | 0.160 |
Why?
|
Electrodes, Implanted | 1 | 2004 | 836 | 0.160 |
Why?
|
Myopia | 1 | 2021 | 254 | 0.160 |
Why?
|
Body Fluids | 2 | 2019 | 321 | 0.150 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2020 | 223 | 0.150 |
Why?
|
Retinitis Pigmentosa | 1 | 2022 | 395 | 0.150 |
Why?
|
Exudates and Transudates | 2 | 2016 | 175 | 0.150 |
Why?
|
Receptors, Purinergic P2Y12 | 1 | 2018 | 117 | 0.150 |
Why?
|
Area Under Curve | 1 | 2021 | 1643 | 0.140 |
Why?
|
Photography | 3 | 2018 | 537 | 0.140 |
Why?
|
Ocular Hypertension | 1 | 2019 | 211 | 0.140 |
Why?
|
Retinal Ganglion Cells | 3 | 2019 | 811 | 0.140 |
Why?
|
Prostheses and Implants | 1 | 2004 | 1277 | 0.140 |
Why?
|
Optic Disk | 2 | 2020 | 421 | 0.140 |
Why?
|
Second Messenger Systems | 1 | 2017 | 203 | 0.140 |
Why?
|
Visual Field Tests | 1 | 2019 | 415 | 0.130 |
Why?
|
Iris | 1 | 1997 | 232 | 0.130 |
Why?
|
Angiography, Digital Subtraction | 1 | 1997 | 331 | 0.130 |
Why?
|
Sensory Thresholds | 1 | 2017 | 377 | 0.130 |
Why?
|
Tissue Adhesions | 1 | 2016 | 223 | 0.120 |
Why?
|
Postoperative Complications | 2 | 2017 | 15833 | 0.120 |
Why?
|
Complement Pathway, Alternative | 1 | 2015 | 113 | 0.120 |
Why?
|
Retrospective Studies | 16 | 2024 | 81760 | 0.120 |
Why?
|
Retinal Pigment Epithelium | 1 | 2018 | 309 | 0.120 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2017 | 423 | 0.120 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 560 | 0.120 |
Why?
|
Dyslipidemias | 1 | 2022 | 873 | 0.110 |
Why?
|
Republic of Korea | 1 | 2016 | 591 | 0.110 |
Why?
|
Capillary Permeability | 3 | 2005 | 772 | 0.110 |
Why?
|
Antibodies, Monoclonal | 3 | 2006 | 9262 | 0.110 |
Why?
|
Lipid Metabolism | 2 | 2022 | 1904 | 0.110 |
Why?
|
Disease Progression | 3 | 2024 | 13668 | 0.100 |
Why?
|
Treatment Outcome | 7 | 2024 | 65379 | 0.100 |
Why?
|
Uveal Neoplasms | 1 | 2016 | 344 | 0.100 |
Why?
|
Eye Injuries, Penetrating | 1 | 2014 | 121 | 0.100 |
Why?
|
Energy Intake | 1 | 2020 | 2146 | 0.100 |
Why?
|
Dietary Fats | 1 | 2020 | 2003 | 0.100 |
Why?
|
Visual Fields | 1 | 2019 | 1065 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 2 | 2022 | 3740 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2020 | 12252 | 0.090 |
Why?
|
Vision Disorders | 1 | 2019 | 1092 | 0.090 |
Why?
|
Laser Coagulation | 2 | 2009 | 333 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2011 | 548 | 0.090 |
Why?
|
Case-Control Studies | 5 | 2024 | 22290 | 0.090 |
Why?
|
Chorioallantoic Membrane | 1 | 2010 | 50 | 0.090 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2202 | 0.090 |
Why?
|
Longitudinal Studies | 3 | 2024 | 14783 | 0.090 |
Why?
|
Adult | 17 | 2024 | 223646 | 0.090 |
Why?
|
Cholesterol, HDL | 1 | 2016 | 1820 | 0.080 |
Why?
|
Animals | 19 | 2019 | 169285 | 0.080 |
Why?
|
Equipment Failure Analysis | 1 | 2012 | 845 | 0.080 |
Why?
|
Microglia | 1 | 2018 | 1376 | 0.080 |
Why?
|
Ischemia | 3 | 2023 | 1900 | 0.080 |
Why?
|
Microvessels | 2 | 2024 | 585 | 0.080 |
Why?
|
Chick Embryo | 1 | 2010 | 975 | 0.080 |
Why?
|
Neoplasms, Second Primary | 1 | 2016 | 1061 | 0.070 |
Why?
|
Enzyme Activation | 2 | 2011 | 3590 | 0.070 |
Why?
|
Cholesterol, LDL | 1 | 2016 | 2403 | 0.070 |
Why?
|
Indocyanine Green | 2 | 1999 | 239 | 0.070 |
Why?
|
Life Style | 1 | 2018 | 3932 | 0.070 |
Why?
|
Endothelial Growth Factors | 2 | 2000 | 672 | 0.070 |
Why?
|
Liposomes | 3 | 1999 | 792 | 0.060 |
Why?
|
Intraocular Pressure | 3 | 2020 | 1304 | 0.060 |
Why?
|
Lymphokines | 2 | 2000 | 925 | 0.060 |
Why?
|
Genome-Wide Association Study | 2 | 2023 | 12795 | 0.060 |
Why?
|
Choroid Neoplasms | 1 | 2006 | 177 | 0.060 |
Why?
|
Ciliary Body | 1 | 2006 | 168 | 0.060 |
Why?
|
Endothelium, Vascular | 3 | 2011 | 4428 | 0.060 |
Why?
|
Risk Factors | 6 | 2018 | 74944 | 0.060 |
Why?
|
Software | 1 | 2019 | 4480 | 0.060 |
Why?
|
Injections | 2 | 2006 | 841 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2018 | 4045 | 0.060 |
Why?
|
Mice, Inbred C57BL | 6 | 2019 | 22380 | 0.060 |
Why?
|
Aging | 1 | 2024 | 8743 | 0.060 |
Why?
|
Blood Vessels | 1 | 2010 | 1110 | 0.060 |
Why?
|
Burkitt Lymphoma | 1 | 2006 | 338 | 0.060 |
Why?
|
Mass Screening | 1 | 2020 | 5458 | 0.060 |
Why?
|
Aorta, Thoracic | 1 | 2010 | 1112 | 0.060 |
Why?
|
Equipment Design | 1 | 2012 | 3522 | 0.050 |
Why?
|
Logistic Models | 1 | 2018 | 13290 | 0.050 |
Why?
|
Comorbidity | 1 | 2018 | 10590 | 0.050 |
Why?
|
Cell Division | 1 | 2011 | 4477 | 0.050 |
Why?
|
Cohort Studies | 2 | 2024 | 41753 | 0.050 |
Why?
|
Ontario | 1 | 2024 | 403 | 0.050 |
Why?
|
Macrophages | 1 | 2018 | 5802 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5520 | 0.050 |
Why?
|
Chronic Disease | 1 | 2018 | 9384 | 0.050 |
Why?
|
Glaucoma | 2 | 2019 | 1194 | 0.050 |
Why?
|
Retinal Degeneration | 2 | 2019 | 414 | 0.050 |
Why?
|
United States | 4 | 2020 | 73039 | 0.050 |
Why?
|
Blotting, Western | 1 | 2010 | 5028 | 0.050 |
Why?
|
Safety | 2 | 2005 | 1159 | 0.050 |
Why?
|
Young Adult | 5 | 2024 | 60066 | 0.050 |
Why?
|
Diet | 1 | 2020 | 8089 | 0.050 |
Why?
|
Time Factors | 3 | 2021 | 40220 | 0.050 |
Why?
|
Cell Death | 2 | 2018 | 1680 | 0.050 |
Why?
|
Capillaries | 1 | 2024 | 755 | 0.050 |
Why?
|
Enzyme Inhibitors | 2 | 2010 | 3728 | 0.050 |
Why?
|
Regional Blood Flow | 1 | 2024 | 1500 | 0.040 |
Why?
|
Phenotype | 1 | 2018 | 16726 | 0.040 |
Why?
|
Body Mass Index | 1 | 2018 | 13053 | 0.040 |
Why?
|
Swine | 1 | 2010 | 5997 | 0.040 |
Why?
|
Mice | 8 | 2019 | 82049 | 0.040 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2000 | 222 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15949 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 14164 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2006 | 6316 | 0.040 |
Why?
|
Carrier State | 1 | 2022 | 529 | 0.040 |
Why?
|
Retinal Vein | 1 | 1997 | 47 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2011 | 19025 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2019 | 3782 | 0.040 |
Why?
|
Dextrans | 1 | 2000 | 574 | 0.040 |
Why?
|
GTP-Binding Proteins | 1 | 2022 | 948 | 0.040 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 1997 | 142 | 0.040 |
Why?
|
Melanoma | 1 | 2016 | 5706 | 0.040 |
Why?
|
Epoxide Hydrolases | 1 | 2017 | 122 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2004 | 2125 | 0.030 |
Why?
|
Atrophy | 1 | 2022 | 1646 | 0.030 |
Why?
|
Reference Values | 1 | 2024 | 4939 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14729 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2010 | 14488 | 0.030 |
Why?
|
Hyperoxia | 1 | 1997 | 261 | 0.030 |
Why?
|
Body Weights and Measures | 1 | 2016 | 208 | 0.030 |
Why?
|
Prognosis | 1 | 2016 | 30009 | 0.030 |
Why?
|
Infusions, Intravenous | 2 | 1999 | 2230 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2004 | 1703 | 0.030 |
Why?
|
Visual Perception | 1 | 2004 | 1401 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2018 | 9561 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2359 | 0.030 |
Why?
|
Coloring Agents | 1 | 1997 | 564 | 0.030 |
Why?
|
Databases, Factual | 2 | 2024 | 8080 | 0.030 |
Why?
|
Nitric Oxide Synthase | 1 | 1997 | 911 | 0.030 |
Why?
|
Eye Infections | 1 | 2014 | 63 | 0.030 |
Why?
|
Pigment Epithelium of Eye | 1 | 2014 | 209 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20225 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2019 | 11095 | 0.030 |
Why?
|
Lens Capsule, Crystalline | 1 | 1992 | 38 | 0.030 |
Why?
|
Drug Substitution | 1 | 2015 | 291 | 0.030 |
Why?
|
Laser Therapy | 1 | 1999 | 1107 | 0.030 |
Why?
|
Drug Carriers | 1 | 1996 | 710 | 0.020 |
Why?
|
Cell Survival | 2 | 2018 | 5789 | 0.020 |
Why?
|
Uveitis | 1 | 2014 | 398 | 0.020 |
Why?
|
SEER Program | 1 | 2016 | 1444 | 0.020 |
Why?
|
Light | 1 | 1996 | 1355 | 0.020 |
Why?
|
Observer Variation | 1 | 2016 | 2621 | 0.020 |
Why?
|
Blood Pressure | 2 | 2016 | 8543 | 0.020 |
Why?
|
Leukocytes | 1 | 2017 | 2034 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2661 | 0.020 |
Why?
|
Cell Count | 2 | 2006 | 1832 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2006 | 5432 | 0.020 |
Why?
|
Incidence | 2 | 2016 | 21538 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3814 | 0.020 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2000 | 749 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2015 | 4620 | 0.020 |
Why?
|
Tyrosine | 1 | 2011 | 1427 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15869 | 0.020 |
Why?
|
Regression Analysis | 1 | 2015 | 6340 | 0.020 |
Why?
|
Tonometry, Ocular | 1 | 2006 | 238 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2020 | 3447 | 0.020 |
Why?
|
Mice, Inbred DBA | 1 | 2006 | 624 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2006 | 9118 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6082 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2006 | 611 | 0.020 |
Why?
|
Gene Expression | 1 | 1997 | 7601 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2022 | 7876 | 0.010 |
Why?
|
Antigens, CD | 1 | 2015 | 4035 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2017 | 3589 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4064 | 0.010 |
Why?
|
Adolescent | 3 | 2016 | 89169 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9669 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1997 | 12801 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2006 | 2560 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2006 | 13586 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2006 | 1836 | 0.010 |
Why?
|
Neoplasms | 1 | 2011 | 22371 | 0.010 |
Why?
|
Blood Glucose | 1 | 2016 | 6431 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12543 | 0.010 |
Why?
|
HIV Seropositivity | 1 | 2006 | 966 | 0.010 |
Why?
|
Ultrasonography | 1 | 2014 | 6004 | 0.010 |
Why?
|
Genotype | 1 | 2015 | 13045 | 0.010 |
Why?
|
Phosphorylation | 1 | 2011 | 8316 | 0.010 |
Why?
|
Cytokines | 1 | 2014 | 7452 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 13013 | 0.010 |
Why?
|
Retreatment | 1 | 1999 | 598 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2000 | 1379 | 0.010 |
Why?
|
Molecular Weight | 1 | 2000 | 2173 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 1997 | 262 | 0.010 |
Why?
|
N-Methylaspartate | 1 | 1997 | 231 | 0.010 |
Why?
|
Retinal Artery Occlusion | 1 | 1997 | 83 | 0.010 |
Why?
|
Microspheres | 1 | 2000 | 788 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1997 | 1553 | 0.010 |
Why?
|
Optic Nerve | 1 | 1999 | 571 | 0.010 |
Why?
|
Optic Nerve Diseases | 1 | 1999 | 342 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 10763 | 0.010 |
Why?
|
Infant | 1 | 2016 | 36535 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 18065 | 0.010 |
Why?
|
Child, Preschool | 1 | 2016 | 42669 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36741 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 1997 | 1880 | 0.010 |
Why?
|
Lenses, Intraocular | 1 | 1992 | 141 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20762 | 0.010 |
Why?
|
Cataract Extraction | 1 | 1992 | 464 | 0.000 |
Why?
|
RNA | 1 | 1997 | 2722 | 0.000 |
Why?
|
Child | 1 | 2016 | 80917 | 0.000 |
Why?
|
Signal Transduction | 1 | 2011 | 23648 | 0.000 |
Why?
|
Oxygen | 1 | 1997 | 4270 | 0.000 |
Why?
|